De esta transferencia se forma GlcNAc-P. Una vez llega a la membrana, se une a esta quedando el GPI en la cara extracelular. Un ejemplo de control primario se encuentra en las diferencias en las cadenas laterales de glicanos en las GPI en la enzima membrana dipeptidasa entre humanos y bovinos. Y un ejemplo de control secundario es la diferencia entre las cadenas laterales de glicano de VSG V ariant S urface G licoprotein cuando algunas de estas enzimas con diferentes secuencias carboxi-terminales se expresan en el mismo trypanosoma.

Author:Gardarg Kazragore
Language:English (Spanish)
Published (Last):1 November 2008
PDF File Size:5.95 Mb
ePub File Size:20.23 Mb
Price:Free* [*Free Regsitration Required]

Universidad Industrial de Santander, Bucaramanga, Colombia. The signaling pathway of phosphatidylinositol 3-kinase PI3K is critical in many aspects of growth and cell survival.

The path of PI3K is stimulated physiologically as a result of many growth factors and regulatory factors. Several genetic alterations such as amplification, mutation and chromosomal arrangements may compromise the PI3K pathway, generating permanent activation in different cancer types have found evidence of these deleterious genetic modifications. Abnormal activation of the PI3K pathway results in alteration of the control mechanisms of growth and cell survival, which favors the competitive growth, and frequently metastatic capacity, greater resistance to treatment.

Figura 1. FKHR; forkhead. GDP; ganosita difosfato. IRS; sustrato receptor de insulina. PIP2; fosfatidil inositol 3,4 difosfato. PIP3; fosfatidil inositol 3,4,5 trifosfato. PKC; protein kinasa C. Vol 4, ; Existen tres tipos de PI3K. Tabla 1. Se han identificado diferentes PDK2 potenciales.

Figura 2. Figura 3. Estas mutaciones ocurren con mayor frecuencia en canceres HER2-amplificados y en positivos para receptor hormonal Tabla 2. Tabla 3. Tabla 4. Funciones asociados a las diferentes isoformas de p de PI3K. CP realizo el primer manuscrito.

Todos los autores leyeron y aprobaron el manuscrito final. Phosphatidylinositol 3-kinase:structure and expression of the kd catalytic subunit. Phosphoinositide kinases. Annu Rev Biochem. Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase.

Embo J. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. Pawson T, Nash P. Protein-protein interactions define specificity in signal transduction.

Genes Dev. Proliferative defect and embryonic lethality in mice homozygous for a deletion in the palpha subunit of phosphoinositide 3-kinase. J Biol Chem. Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice.

Mol Cell Biol. Impaired B and T cell antigen receptor signaling in pdelta PI 3-kinase mutant mice. Key role of the pdelta isoform of PI3K in B-cell antigen and IL-4 receptor signaling:comparative analysis of genetic and pharmacologic interference with pdelta function in B cells. Upregulated function of phosphatidylinositolkinase in genetically hypertensive rats:a moderator of arterial hypercontractility. Clin Exp Pharmacol Physiol.

Essential role for the pdelta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia. Cancer Res. Over-expression of the pbeta but not palpha isoform of PI 3-kinase inhibits motility in breast cancer cells. Cell Motil Cytoskeleton. Phosphatidylinositide 3-kinase gamma regulates key pathologic responses to cholecystokinin in pancreatic acinar cells. Class I phosphoinositide 3-kinase pbeta is required for apoptotic cell and Fcgamma receptor-mediated phagocytosis by macrophages.

Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways. Circ Res. Targeted inhibition of beta-adrenergic receptor kinaseassociated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression.

J Am Coll Cardiol. PI 3-kinase pbeta:a new target for antithrombotic therapy. Nat Med. Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families. Eur J Biochem. Cytogenet Cell Genet. Mechanism of activation of protein kinase B by insulin and IGF A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region.

Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Integrin-linked kinase regulates phosphorylation of serine of protein kinase B by an indirect mechanism.

Protein kinase C betaII regulates Akt phosphorylation on Ser in a cell type- and stimulus-specific fashion. Testa JR, Bellacosa A. AKT plays a central role in tumorigenesis. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2.

Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. Targeting the PI3K-Akt pathway in human cancer:rationale and promise. Cancer Cell. MDM2 in Breast Cancer. Breast Cancer. Curr Opin Genet Dev. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Phosphatidylinositol 3-kinase signaling inhibits DAF DNA binding and function via dependent and independent pathways. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy.

Schmelzle T, Hall MN. TOR, a central controller of cell growth. Translational control of the antiapoptotic function of Ras. Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin mTOR -mediated downstream signaling. Tuberous sclerosis genes regulate cellular protein levels.

Biochem Biophys Res Commun. J Cell Biol. J Clin Invest. Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Hay N. The Akt-mTOR tango and its relevance to cancer. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress.

Phosphorylation of p27Kip1 at threonine by p90 ribosomal protein S6 kinases promotes its binding to and cytoplasmic localization.

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Role of VHL gene mutation in human cancer.


2010, NĂºmero 2

Eyster KM. The membrane and lipids as integral participants in signal transduction: lipid signal transduction for the non-lipid biochemist. Adv Physiol Educ ; Activation of phospholipase C beta 2 by the alpha and beta gamma subunits of trimeric GTP-binding protein.





Fosfoinositol 3-quinasa


Related Articles